Sequential Bio - About the company
Sequential Bio is a series A company based in New York City (United States), founded in 2019 by Oliver Worsley and Albert Dashi. It operates as a Provider of in-vivio microbiome testing platform for skin care. Sequential Bio has raised $7.5M in funding from investors like IndieBio, Sparkfood and Metaplanet. The company has 5 active competitors, including 3 that are funded. Its top competitors include companies like Parallel Health, Sapere Bio and Eykona Technologies.
Company Details
Provider of in-vivio microbiome testing platform for skin care. The company offers at-home skin microbiome tests, through the Sequential Skin patch for skin care, scalp care, intimate care, or oral care.
Key Metrics
Founded Year
2019
Location
New York City, United States
Stage
Series A
Total Funding
$7.5M in 6 rounds
Latest Funding Round
Ranked
1st among 5 active competitors
Employee Count
25 as on Sep 30, 2026
Similar Companies
Legal entities associated with Sequential Bio
Sequential Bio is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
SEQUENTIAL SKIN INC. CIN: 6392583 , United States, Active | Nov 29, 2021 | - | - | - |
SEQUENTIAL SKIN LTD CIN: 12547483 , United Kingdom, Active | Apr 05, 2020 | - | 4 (As on Mar 31, 2025) |
Sign up to download Sequential Bio's company profile
Sequential Bio's funding and investors
Sequential Bio has raised a total funding of $7.5M over 6 rounds. Its first funding round was on Mar 17, 2021. Its latest funding round was a Series A round on Mar 17, 2026 for $*****. 5 investors participated in its latest round. Sequential Bio has 8 institutional investors and 3 angel investors.
Here is the list of recent funding rounds of Sequential Bio:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 17, 2026 | 3286099 | Series A | 3577535 | 5437102 | 8432668 | 6913651 |
May 25, 2023 | 5343493 | Seed | 2193752 | 1989704 | 9331742 | |
Oct 2022 | 1164998 | Seed | 5508532 | 9118814 | 5480222 |
Access funding benchmarks and valuations. Sign up today!View details of Sequential Bio's funding rounds and investors
Sequential Bio's founders and board of directors
Founder? Claim ProfileThe founders of Sequential Bio are Oliver Worsley and Albert Dashi. Oliver Worsley is the CEO of Sequential Bio.
Here are the details of Sequential Bio's key team members:
- Oliver Worsley: Co-Founder & CEO of Sequential Bio and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address
- Albert Dashi: Co-Founder of Sequential Bio and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address
Sequential Bio's Board of Directors
Sequential Bio's board has 2 active members. Oliver Worsley and Albert Dashi are part of team.Here is the list of Sequential Bio's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 6y 6m | |
gytpvpd | Team | - | Past | 8y 2m |
View details of Sequential Bio's Founder profiles and Board Members
Sequential Bio's employee count trend
Sequential Bio has 25 employees as of Sep 26. Here is Sequential Bio's employee count trend over the years:
Uncover Sequential Bio's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sequential Bio's Competitors and alternates
Top competitors of Sequential Bio include Parallel Health, Sapere Bio and Eykona Technologies. Here is the list of Top 10 competitors of Sequential Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Sequential Bio 2019, New York City (United States), Series A | Provider of in-vivio microbiome testing platform for skin care | $7.5M | 63/100 | |
2nd | Parallel Health 2020, San Francisco (United States), Seed | Provider of microbiome based test for personalized skin care products | - | 48/100 | |
3rd | Sapere Bio 2013, Raleigh (United States), Seed | Diagnostic company that develops non-invasive biomarker tests to measure cellular aging and predict the risk of age-related diseases | $500K | 27/100 | |
4th | Eykona Technologies 2007, Oxford (United Kingdom), Late Stage | Provider of portable 3D imaging systems for dermatological applications | $1.86M | 27/100 | |
5th | Milieu 2024, Ann Arbor (United States), Funding Raised | Developer of skincare products and microbiome analysis for personalized skin health | - | 19/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Sequential Bio's competitors? Click here to see the top ones
Sequential Bio's Investments and acquisitions
Sequential Bio has made no investments or acquisitions yet.
Reports related to Sequential Bio
Here is the latest report on Sequential Bio's sector:
News related to Sequential Bio
Filter this listMedia has covered Sequential Bio for 1 event in last 1 year.
•
Sequential Raises $3.5M in FundingFinSMEs•Mar 17, 2026•Dermazone, Sparkfood, Sequential Bio, Corundum Systems Biology and 4 others
•
UK-Singapore collaboration advances gut-skin microbiome science with $1.8M grantBioSpectrum Asia•Apr 28, 2025•AMILI, Sequential Bio
•
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome SciencePR Newswire•Feb 13, 2025•AMILI, Sequential Bio
•
Corundum System Biology Co., Ltd. Random System Biology invests in bio-venture specializing in skin healthhttp://re-how.net•May 25, 2023•Sequential Bio, Corundum Systems Biology
•
Sequential Announces New Collaboration Agreement to Measure Skin Health for Leading Developer of Personal Care Products.BioPharmaDive•Mar 15, 2023•Sequential Bio, Johnson & Johnson
•
Symbiome Partners with Skin Microbiome Testing experts at Sequential to Revolutionize Beauty IndustryEIN Presswire•Jan 26, 2023•Symbiome, Sequential Bio
•
•
Sequential Bio wins prestigious Allē Award: Recognised as "Most Significant" Testing Method in the IndustryPR Newswire•Oct 03, 2022•Sequential Bio
•
Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forwardPR Newswire•Jun 29, 2022•Ukri, Sequential Bio
•
Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forwardPR Newswire•Jun 09, 2022•Sequential Bio, Innovate UK
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Sequential Bio
Explore our recently published companies
- Hello Syndic - Paris based, 2017 founded, Unfunded company
- Giddaa - Middletown based, 2023 founded, Unfunded company
- Assistive - San Francisco based, 2023 founded, Unfunded company
- Himalayanorganicindia - India based, Unfunded company
- Sierra Technology and Business - Saudi Arabia based, 2023 founded, Unfunded company
- Energy3K - Unfunded company
